Boogerd Leonora Sf, van der Valk Maxime Jm, Boonstra Martin C, Prevoo Hendrica Ajm, Hilling Denise E, van de Velde Cornelis Jh, Sier Cornelis Fm, Fariña Sarasqueta Arantza, Vahrmeijer Alexander L
Department of Surgery.
Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
Onco Targets Ther. 2018 Mar 23;11:1655-1664. doi: 10.2147/OTT.S145473. eCollection 2018.
Intraoperative identification of rectal cancer (RC) can be challenging, especially because of fibrosis after treatment with preoperative chemo- and radiotherapy (CRT). Tumor-targeted fluorescence imaging can enhance the contrast between tumor and normal tissue during surgery. Promising targets for RC imaging are carcinoembryonic antigen (CEA), epithelial cell adhesion molecule (EpCAM) and the tyrosine-kinase receptor Met (c-Met). The effect of CRT on their expression determines their applicability for imaging. Therefore, we investigated whether CRT modifies expression patterns in tumors, lymph node (LN) metastases and adjacent normal rectal tissues.
Preoperative biopsies, primary tumor specimens and metastatic LNs were collected from 38 RC patients who did not receive CRT (cohort 1) and 34 patients who did (cohort 2). CEA, EpCAM and c-Met expression was determined using immunohistochemical staining and was semiquantified by a total immunostaining score (TIS), consisting of the percentage and intensity of stained tumor cells (0-12).
In both cohorts CEA, EpCAM and c-Met were significantly highly expressed in >60% of tumor tissues compared with adjacent normal epithelium (T/N ratio, <0.01). EpCAM showed the most homogenous expression in tumors, whereas CEA showed the highest T/N ratio. Most importantly, CEA and EpCAM expression did not significantly change in normal or neoplastic RC tissue after CRT, whereas levels of c-Met changed (=0.02). Tissues of eight patients with a pathological complete response after CRT showed expression of all biomarkers with TIS close to normal epithelium.
Histological evaluation shows that CEA, EpCAM and c-Met are suitable targets for RC imaging, because all three are significantly enhanced in cancer tissue from primary tumors or LN metastases compared with normal adjacent tissue. Furthermore, the expression of CEA and EpCAM is not significantly changed after CRT. These data underscore the applicability of c-Met and especially, CEA and EpCAM as targets for image-guided RC surgery, both before and after CRT.
术中识别直肠癌(RC)可能具有挑战性,尤其是由于术前放化疗(CRT)治疗后出现纤维化。肿瘤靶向荧光成像可在手术期间增强肿瘤与正常组织之间的对比度。RC成像有前景的靶点是癌胚抗原(CEA)、上皮细胞粘附分子(EpCAM)和酪氨酸激酶受体Met(c-Met)。CRT对其表达的影响决定了它们在成像中的适用性。因此,我们研究了CRT是否会改变肿瘤、淋巴结(LN)转移灶及相邻正常直肠组织中的表达模式。
从38例未接受CRT的RC患者(队列1)和34例接受CRT的患者(队列2)中收集术前活检组织、原发性肿瘤标本和转移性LN。使用免疫组织化学染色确定CEA、EpCAM和c-Met的表达,并通过总免疫染色评分(TIS)进行半定量,TIS由染色肿瘤细胞的百分比和强度组成(0-12)。
在两个队列中,与相邻正常上皮相比,超过60%的肿瘤组织中CEA、EpCAM和c-Met均显著高表达(T/N比值,<0.01)。EpCAM在肿瘤中的表达最均匀,而CEA的T/N比值最高。最重要的是,CRT后正常或肿瘤性RC组织中CEA和EpCAM的表达没有显著变化,而c-Met的水平发生了变化(P=0.02)。8例CRT后病理完全缓解患者的组织显示所有生物标志物的表达,TIS接近正常上皮。
组织学评估表明,CEA、EpCAM和c-Met是RC成像的合适靶点,因为与相邻正常组织相比,这三种标志物在原发性肿瘤或LN转移灶的癌组织中均显著增强。此外,CRT后CEA和EpCAM的表达没有显著变化。这些数据强调了c-Met,尤其是CEA和EpCAM作为CRT前后图像引导RC手术靶点的适用性。